Breyer Capital
Breyer Capital is a family-controlled venture capital firm founded by Jim Breyer that invests across AI/healthcare, consumer software, fintech, enterprise data, security, and climate sectors, sourcing deals through founder networks and university partnerships with patient capital.
- Company typePrivate
- Founded2012
- HeadquartersMenlo Park, United States
- Headcount1–10
- GTM typeB2B
- OfferingServices
What Breyer Capital does
Breyer Capital is a privately-held, family-controlled venture capital and private equity firm founded by Jim Breyer that invests across multiple technology sectors with anchor themes in artificial intelligence, healthcare and life sciences, consumer software, media and gaming, fintech, enterprise and data, security and defense technology, and climate. The firm positions itself as a long-term, high-conviction investor that commits capital at inception and supports portfolio companies through institutional scale, sourcing opportunities primarily through founder networks, university partnerships, and reputation-driven deal flow rather than competitive auctions.
The firm's business model follows the standard venture capital structure of charging management fees on committed capital and earning carried interest from successful portfolio exits. Notable historical investments include Facebook (lead investor in the 2005 first institutional round, returning over 100x), Etsy, Legendary, Marvel Entertainment, Spotify, 21st Century Fox, and Circle, with more recent investments spanning AI-driven medicine (Pathway Labs, ParcelBio, Soley Therapeutics, OpenEvidence, Hippocratic AI, Ambience Healthcare), fintech and crypto infrastructure (Circle, Catena Labs, EigenLayer, Chia, ZenBusiness), consumer (Grammarly, Headspace, Epic Games, Zepto, Taager), and enterprise AI/quantum (Sandbox AQ, Shield AI). The firm operates from Austin, Texas (headquarters since 2020) and Menlo Park, California, with a small core team supplemented by partners Daniel and Ted Breyer, Partner Morgan Cheatham (Head of Healthcare and Life Sciences), and venture advisors including former IBM CEO Samuel Palmisano and physician-scientist Dr. Bret Bostwick.
The firm has increasingly emphasized healthcare AI as a core thesis, supported by the strategic partnership with Harvard Medical School's AI in Medicine (AIM) PhD track and the appointment of clinically-trained venture advisors. Geographic reach extends across North America, Europe (Sweden), the Middle East (Saudi Arabia, UAE, Egypt), Asia (India), and Africa (Kenya) through portfolio company operations and co-investor networks, though deployment remains concentrated in U.S.-headquartered companies.
Breyer Capital firmographics
Firmographics- Name
- Breyer Capital
- Legal name
- Breyer Capital L.L.C.
- Website
- https://breyercapital.com
- Company type
- Private
- Founded year
- 2012
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Breyer Capital is a family-controlled venture capital firm founded by Jim Breyer that invests across AI/healthcare, consumer software, fintech, enterprise data, security, and climate sectors, sourcing deals through founder networks and university partnerships with patient capital.
- Ownership category
- akta.pro rank
Breyer Capital industry classification
Industry- Product category
- Venture Capital and Private Equity
- NAICS
- Portfolio Management and Investment Advice (52394), Portfolio Management and Investment Advice (523940)
- SIC
- Investment Advice (6282)
- akta.pro primary industry
- Technology & Software Growth Equity (FSANACAA)
Keywords
Where Breyer Capital is headquartered
LocationHeadquarters
- HQ city
- Menlo Park
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Breyer Capital business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D
Revenue model
- Management Fees: Standard VC management fee structure charged on committed capital
- Carried Interest: Performance-based carried interest from successful portfolio company exits and realizations
Go-to-market motion1 record
Distribution channels3 records
Marketing channels5 records
Breyer Capital product offering
Product offeringCore offering
Breyer Capital is a venture capital and private equity firm that invests patient capital in early-stage and growth-stage technology and healthcare companies alongside strategic guidance, board participation, and hands-on operational support. The firm's portfolio spans AI and AI health, quantum, consumer software, media and gaming, fintech, enterprise and data, security and defense tech, and climate sectors, with capital deployed from inception through institutional scale.
Product overview
Breyer Capital is a premier venture capital firm focused on catalyzing high-impact entrepreneurs. The firm does not offer a unified product platform; rather, it provides investment capital, strategic guidance, and partnership support to early-stage companies. Breyer Capital's investment strategy centers on artificial intelligence and machine learning, healthcare and life sciences, consumer software, media and gaming, fintech, enterprise and data technologies, security and defense technology, and climate solutions. The firm partners with founders at inception and through growth stages, offering patient capital and hands-on support across portfolio companies.
Differentiator
Problem solved
Functional benefit
Companies that use Breyer Capital
Customer profileNamed customers6 records
Segments4 records
Ideal customer profiles4 records
Breyer Capital technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Breyer Capital partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- Dr. Bret BostwickcoreDr. Bret Bostwick, physician-scientist with Alnylam Pharmaceuticals experience, appointed as Venture Advisor to strengthen healthcare and life sciences investment platform
- Harvard Medical SchoolcoreBreyer Capital made significant investment to support Harvard Medical School's AI in Medicine (AIM) PhD track, reinforcing its leadership in healthcare AI and commitment to education and innovation
Scale indicators4 records
Recent moves6 records
Expansion highlights5 records
Breyer Capital competitors and assessment
Company assessmentDirect peers
- Bessemer Venture Partners: Long-standing venture firm with deep healthcare/life sciences franchise that incubated Morgan Cheatham before he joined Breyer. Directly comparable in stage, healthcare focus, and B2B/enterprise orientation.
- General Catalyst: Multi-stage venture and transformation firm with substantial healthcare and fintech exposure. Comparable in breadth and stage; co-invested with Breyer in Catena Labs.
- Khosla Ventures: High-conviction, founder-first venture firm with strong AI and healthcare investing practices. Comparable thesis around transformative technology and willingness to invest at inception.
- Greylock Partners: Silicon Valley venture firm with comparable enterprise and consumer focus, and similar concentration on early-stage, high-conviction founder partnerships.
- Founders Fund: Founder-led venture firm investing across deeptech, healthcare, and frontier technology with long-duration capital philosophy comparable to Breyer's patient-capital stance.
- Andreessen Horowitz (a16z): Premier Silicon Valley venture capital firm investing across stages and sectors. Most direct peer to Breyer Capital in scale, sector breadth (consumer, enterprise, fintech, healthcare/AI), and LP-backed fund model; co-invested with Breyer in Catena Labs.
- Accel: Early-stage venture capital firm with similar consumer/internet and enterprise focus. Closely comparable stage and sector profile to Breyer Capital's portfolio.
Broad incumbents
- New Enterprise Associates (NEA): Large diversified venture firm with deep healthcare and technology franchises. Comparable sector breadth to Breyer but materially larger scale and longer fund history.
- Insight Partners: Large venture and growth firm with concentrated software and healthcare exposure. Comparable AI/healthcare thesis but skews toward growth-stage versus Breyer's earlier-stage inception investing.
- Sequoia Capital: Largest and most established venture capital firm with comparable early-stage concentration in tech, healthcare, and fintech. Highly comparable to Breyer in stage and sector, but materially larger AUM and longer fund history.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
Breyer Capital social profiles
Digital presenceBreyer Capital financial estimates
Financial estimateRevenue estimate
Valuation estimate
Breyer Capital leadership team
Management profileNumber of profiles
Profiles7 records
Breyer Capital funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Breyer Capital M&A and investment
M&A and investmentM&A
Investments200 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Breyer Capital
What does Breyer Capital do?
Breyer Capital is a venture capital and private equity firm that invests patient capital in early-stage and growth-stage technology and healthcare companies alongside strategic guidance, board participation, and hands-on operational support. The firm's portfolio spans AI and AI health, quantum, consumer software, media and gaming, fintech, enterprise and data, security and defense tech, and climate sectors, with capital deployed from inception through institutional scale.
Is Breyer Capital a public or private company?
Breyer Capital is a private company. It is classified as family owned and is currently operating.
When was Breyer Capital founded?
Breyer Capital was founded in 2012. It employs 1 to 10 people.
Where is Breyer Capital based?
Breyer Capital is headquartered in Menlo Park, United States, in the North America region.
How does Breyer Capital make money?
Two revenue lines are on record. Management Fees are the primary driver. The others are carried Interest.
Who are Breyer Capital's main competitors?
Direct peers on record are Bessemer Venture Partners, General Catalyst, Khosla Ventures, Greylock Partners, Founders Fund, Andreessen Horowitz (a16z) and Accel. Broad incumbents are New Enterprise Associates (NEA), Insight Partners and Sequoia Capital.
Does Breyer Capital have an API?
No public API is recorded for Breyer Capital.
What industry is Breyer Capital in?
Breyer Capital's product category is Venture Capital and Private Equity. Its primary akta.pro industry code is FSANACAA, Technology & Software Growth Equity. Its NAICS code is 52394 and its SIC code is 6282.